Consultation on updates to sections of drug and natural health product documents

Drug Establishment Licensing Bulletin #169, March 1, 2024

On this page

About the consultation

Health Canada is seeking feedback on select sections of the following revised documents:

The consultation period is from March 1, 2024, to March 22, 2024.

We have updated the guides and form to reflect upcoming changes to the Regulations Amending the Food and Drug Regulations and the Medical Devices Regulations (Recalls, Establishment Licenses and Finished Product Testing).

We're currently analyzing comments received during the previous consultation of GUI-0027 and GUI-0026. We'll consider all of them in the final version of the guidance documents.

Overview of key changes

We're making regulatory changes that modernize Health Canada's regulatory post-market oversight of therapeutic products. With this in mind, we've made the following changes:

How to participate

Email us to ask for the consultation package and to submit your comments by March 22, 2024. We'll consider all comments when we finalize the guidance documents.


Page details

Date modified: